My father was originally diagnosed with multiple myeloma close to 20 years ago. Back then, there were not nearly as many treatment options or clinical trials available to him. Unfortunately, he lost his valiant fight in 2005.
This experience was a driving force in my decision to become a clinical research nurse at Dana-Farber, a world-renowned cancer and research institute, whose entire mission is to eradicate cancer and improve the lives of cancer patients. Every day I help patients and their families navigate through what is an extremely challenging and scary part of their lives. I assist in protocol development and provide clinical care and patient education to patients undergoing investigational treatments.
Dana-Farber is currently involved in over a thousand clinical trials. It is part of the reason our momentum of success continues to accelerate. Since my father passed away, Dana-Farber has continued to lead the way in the development of treatments across all cancers—including multiple myeloma. Lifespans have tripled and there are about 20 new drugs that weren’t available when my father was diagnosed.
My father was passionate about promoting cancer research and increasing awareness. Although I wish my father would have been able to receive or taken part in one of the many clinical trials available today, I know that he would be so proud of our effort to Defy Cancer.
— Meghara Walsh, BSN, RN